Patients considering non-injectable compounded GLP-1 formulations should discuss the expected bioavailability with their provider and pharmacy, and should be cautious about formulations that haven't been validated through pharmacokinetic studies
For injectable Ozempic, its administration is not tied to meal times, offering more flexibility, but the consistent empty-stomach rule for levothyroxine still applies
Summary: GLP-1 receptor agonists may reduce inflammation by decreasing pro-inflammatory cytokines, modulating immune signalling pathways, and indirectly through weight loss and improved metabolic health
Uses a longer needle, causes more discomfort, and is not the standard route for SS-31 in physician-supervised programs
There isnt a standard dose for NAC, but clinical studies for various conditions have used doses ranging from 600 to 1800 milligrams per day, typically divided into 2 or 3 doses